R. McGovern

发表

p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis.

D. Schaid, J. Cunningham, A. Hartmann, 1994, Oncogene.

Propsective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function

Thomas R Larson, A. Rule, K. Kashani, 2021, Clinical and translational science.

Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas.

B. Vogelstein, J. Kovach, S. Sommer, 1991, Journal of the National Cancer Institute.

UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine

S. Mandrekar, M. Goetz, R. Goldberg, 2013, Investigational New Drugs.

A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies

G. Wilding, J. Kolesar, J. Eickhoff, 2013, Investigational New Drugs.

A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors

G. Wilding, J. Kolesar, J. Eickhoff, 2013, Investigational New Drugs.

A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors

John D. Roberts, M. Gonen, G. Schwartz, 2011, Investigational New Drugs.

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Rachel A. Kudgus, S. Groshen, J. Maris, 2018, Clinical Cancer Research.

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

R. Gilbertson, C. Ahern, J. Reid, 2013, Pediatric blood & cancer.

Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.

P. Adamson, J. Reid, M. Ames, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overexpression and mutations of p53 in metastatic malignant melanomas

A. Hartmann, J. Kovach, M. Pittelkow, 1996, International journal of cancer.

Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.

David I. Smith, E. Thorland, D. Persing, 2000, Cancer research.

Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.

E. Thorland, D. Persing, B. Gostout, 2000, Cancer research.

Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer

D. Schaid, J. Cunningham, A. Hartmann, 1994, The Lancet.

p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.

J. Cunningham, A. Hartmann, J. Kovach, 1995, Oncogene.

Population Pharmacokinetics of Z‐Endoxifen in Patients With Advanced Solid Tumors

Thomas R Larson, M. Goetz, A. Adjei, 2022, Journal of clinical pharmacology.

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

J. Uhm, R. Arusell, J. Buckner, 2010, Journal of Neuro-Oncology.

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

M. A. Mahr, Minetta C. Liu, D. Visscher, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential distribution of sequence variations in HPV-16 E6.

D. Persing, B. Gostout, R. McGovern, 2000, Gynecologic oncology.

Cervical cancer in older women: a molecular analysis of human papillomavirus types, HLA types, and p53 mutations.

D. Persing, K. Podratz, B. Gostout, 1998, American journal of obstetrics and gynecology.

A tandem CC → TT transition in the p53 gene of a breast cancer

A. Hartmann, J. Kovach, H. Blaszyk, 1994, Human mutation.

Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.

J. Cunningham, J. Kovach, S. Sommer, 1992, Journal of the National Cancer Institute.

Skeletal and Uterotrophic Effects of Endoxifen in Female Rats

M. Goetz, J. Ingle, J. Reid, 2017, Endocrinology.

Phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with temozolomide (TMZ) in patients with malignant gliomas (NABTC 04–03)

Susan M. Chang, M. Prados, P. Wen, 2007 .

Combined local delivery of tacrolimus and stem cells in hydrogel for enhancing peripheral nerve regeneration

K. Zuo, J. Reid, G. Borschel, 2021, Biotechnology and bioengineering.

LC-MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501).

L. Jia, J. Reid, M. Ames, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.

M. Davis, D. Persing, M. Pittelkow, 2000, Journal of the American Academy of Dermatology.

Mouse pharmacokinetics and metabolism of the phenylurea thiocarbamate NSC 161128

Rachel A. Kudgus, J. Reid, M. Ames, 2022, Cancer Chemotherapy and Pharmacology.

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

K. Kalari, M. Goetz, J. Ingle, 2020, Breast Cancer Research.

A phase I trial of MK‐2206 in children with refractory malignancies: A Children's Oncology Group study

P. Houghton, C. Ahern, L. Doyle, 2014, Pediatric blood & cancer.

Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group

A. Naranjo, W. London, S. Cohn, 2011, Clinical Cancer Research.

Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma

David I. Smith, E. Thorland, M. Ferber, 2003, Oncogene.

Human papillomavirus in vulvar vestibulitis syndrome.

B. Gostout, R. McGovern, A. Good, 2007, The Journal of reproductive medicine.

Vaginal Diazepam for Nonrelaxing Pelvic Floor Dysfunction: The Pharmacokinetic Profile.

Rachel A. Kudgus, Lisa E. Vaughan, J. Reid, 2019, The journal of sexual medicine.

Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component

Rachel A. Kudgus, J. Reid, P. Mukherjee, 2014, Scientific Reports.

A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2

John D. Roberts, G. Shapiro, S. Grant, 2013, Clinical Cancer Research.

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors

P. Choyke, L. Rubinstein, J. Doroshow, 2021, Oncotarget.

High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.

J. Cunningham, A. Hartmann, J. Kovach, 1996, British Journal of Cancer.

TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk.

S. Cha, E. Calhoun, J. Sloan, 2003, Gynecologic oncology.

Host genetic polymorphism analysis in cervical cancer.

Stephen J Iturria, David I. Smith, James R Cerhan, 2002, Clinical chemistry.

Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.

A. Weaver, A. Clayton, J. Kasperbauer, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Two cases of coincident carcinomas of the head and neck and the uterine cervix.

A. Clayton, M. J. Webb, K. Olsen, 2002, Gynecologic oncology.

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

C. Ahern, J. Reid, M. Ames, 2013, Pediatric blood & cancer.

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

J. Sloan, P. Novotny, A. Clayton, 2012, American journal of obstetrics and gynecology.

Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03

Susan M. Chang, W. Yung, M. Prados, 2012, Clinical Cancer Research.

Epstein‐Barr Virus DNA Is Not Increased in Tonsillar Carcinoma

J. Kasperbauer, B. Gostout, S. Strome, 2001, The Laryngoscope.

Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models

V. Steele, A. Bode, I. Stijleman, 2015, Cancer Prevention Research.

Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications

E. Perlstein, Christina Lam, D. Cassiman, 2021, Annals of neurology.

Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines

M. Ames, R. McGovern, K. J. Miller, 2004, Cancer Chemotherapy and Pharmacology.

Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

E. Calhoun, A. Clayton, B. Gostout, 2004, Gynecologic oncology.

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

Krishna R. Kalari, K. Kalari, M. Goetz, 2020, Breast Cancer Research.

Consensus-degenerate hybrid oligonucleotide primers (CODEHOP) for the detection of novel papillomaviruses and their application to esophageal and tonsillar carcinomas.

D. Persing, B. Gostout, R. McGovern, 2005, Journal of virological methods.

Neuroprotection mediated by inhibition of calpain during acute viral encephalitis

C. Howe, J. Reid, E. Buenz, 2016, Scientific Reports.

Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting.

A. Hartmann, J. Kovach, H. Blaszyk, 1995, BioTechniques.

Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates

J. Reid, M. Ames, J. Nuchtern, 2007, Cancer Chemotherapy and Pharmacology.

Novel pattern of P53 mutation in breast cancers from Austrian women.

D. Schaid, J. Cunningham, A. Hartmann, 1995, The Journal of clinical investigation.

Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3

V. Steele, A. Bode, I. Stijleman, 2015, Cancer Prevention Research.

Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populations.

D. Schaid, J. Cunningham, A. Hartmann, 1996, Oncogene.

A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.

M. Goetz, C. Erlichman, J. Reid, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

S. Mandrekar, W. Harmsen, E. Szabo, 2008, Cancer Epidemiology Biomarkers & Prevention.

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

J. Sloan, P. Novotny, A. Clayton, 2012, American journal of obstetrics and gynecology.

Advances in Brief Human Papillomavirus Type 16 Integrations in Cervical Tumors Frequently Occur in Common Fragile Sites 1

David I. Smith, E. Thorland, D. Persing, 2000 .

Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models

V. Steele, A. Bode, I. Stijleman, 2015, Cancer Prevention Research.